Position in AMGN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$3,203,313
-$416,167 QoQ
Shares Held
8,846
-14.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#1,041
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Investment Advisory Services, LLC holds $45,032,363 across 13 Drug Manufacturers - General names. AMGN ranks #6 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,697 | $10,431,443 | |
| 2 | JNJ |
Johnson & Johnson
|
35,778 | $9,086,538 | |
| 3 | ABBV |
AbbVie Inc.
|
35,075 | $8,826,273 | |
| 4 | PFE |
Pfizer Inc
|
200,077 | $4,817,854 | |
| 5 | MRK |
Merck & Co., Inc.
|
29,988 | $3,853,458 | |
| 6 | AMGN |
Amgen Inc
This page
|
8,846 | $3,203,313 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
32,911 | $1,896,331 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,218 | $785,582 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,203,313 | 8,846 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $3,619,480 | 10,287 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $3,391,913 | 10,363 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $2,891,421 | 10,246 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $2,961,859 | 10,608 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $3,275,948 | 10,515 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $2,613,176 | 10,026 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $3,179,890 | 9,869 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $3,469,757 | 11,105 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,038,527 | 10,687 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $3,423,981 | 11,888 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $3,234,257 | 12,034 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $2,673,564 | 12,042 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $2,439,741 | 10,092 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $2,630,864 | 10,017 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $2,010,568 | 8,920 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $2,180,211 | 8,961 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $2,203,463 | 9,112 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $2,055,775 | 9,138 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $1,839,209 | 8,649 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $2,079,431 | 8,531 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $2,135,287 | 8,582 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $2,014,099 | 8,760 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $1,884,596 | 7,415 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $1,648,897 | 6,991 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,412,014 | 6,965 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||